Rowe M - Search Results

1

Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes.

Rowe M, Lear AL, Croom-Carter D, Davies AH, Rickinson AB. Rowe M, et al. J Virol. 1992 Jan;66(1):122-31. doi: 10.1128/JVI.66.1.122-131.1992. J Virol. 1992. PMID: 1309242 Free PMC article.

2

Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification.

Shannon-Lowe C, Adland E, Bell AI, Delecluse HJ, Rickinson AB, Rowe M. Shannon-Lowe C, et al. Among authors: rowe m. J Virol. 2009 Aug;83(15):7749-60. doi: 10.1128/JVI.00108-09. Epub 2009 May 13. J Virol. 2009. PMID: 19439479 Free PMC article.

3

Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.

Rowe M, Kelly GL, Bell AI, Rickinson AB. Rowe M, et al. Semin Cancer Biol. 2009 Dec;19(6):377-88. doi: 10.1016/j.semcancer.2009.07.004. Epub 2009 Jul 18. Semin Cancer Biol. 2009. PMID: 19619657 Free PMC article. Review.

4

The Epstein-Barr virus BamHI C promoter is not essential for B cell immortalization in vitro, but it greatly enhances B cell growth transformation.

Tierney RJ, Nagra J, Rowe M, Bell AI, Rickinson AB. Tierney RJ, et al. Among authors: rowe m. J Virol. 2015 Mar;89(5):2483-93. doi: 10.1128/JVI.03300-14. Epub 2014 Dec 24. J Virol. 2015. PMID: 25540367 Free PMC article.

5

Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promoter usage.

Kerr BM, Lear AL, Rowe M, Croom-Carter D, Young LS, Rookes SM, Gallimore PH, Rickinson AB. Kerr BM, et al. Among authors: rowe m. Virology. 1992 Mar;187(1):189-201. doi: 10.1016/0042-6822(92)90307-b. Virology. 1992. PMID: 1310556

6

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.

Murray RJ, Kurilla MG, Brooks JM, Thomas WA, Rowe M, Kieff E, Rickinson AB. Murray RJ, et al. Among authors: rowe m. J Exp Med. 1992 Jul 1;176(1):157-68. doi: 10.1084/jem.176.1.157. J Exp Med. 1992. PMID: 1319456 Free PMC article.

7

The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.

Lear AL, Rowe M, Kurilla MG, Lee S, Henderson S, Kieff E, Rickinson AB. Lear AL, et al. Among authors: rowe m. J Virol. 1992 Dec;66(12):7461-8. doi: 10.1128/JVI.66.12.7461-7468.1992. J Virol. 1992. PMID: 1331531 Free PMC article.

8

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death.

Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E, Rickinson A. Henderson S, et al. Among authors: rowe m. Cell. 1991 Jun 28;65(7):1107-15. doi: 10.1016/0092-8674(91)90007-l. Cell. 1991. PMID: 1648447

9

The Epstein-Barr virus carrier state: dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers.

Yao QY, Rowe M, Martin B, Young LS, Rickinson AB. Yao QY, et al. Among authors: rowe m. J Gen Virol. 1991 Jul;72 ( Pt 7):1579-90. doi: 10.1099/0022-1317-72-7-1579. J Gen Virol. 1991. PMID: 1649896

10

Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man.

Rowe M, Young LS, Crocker J, Stokes H, Henderson S, Rickinson AB. Rowe M, et al. J Exp Med. 1991 Jan 1;173(1):147-58. doi: 10.1084/jem.173.1.147. J Exp Med. 1991. PMID: 1845872 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,299 results

Search Page

Filters